Drugs to undergo their efficacy equivalence test will benefit from the insurance coverage

Published: 2002-04-22 06:58:00

Updated: 2002-04-22 06:58:00

The MOHW has announced that of the items whose application for the drug efficacy equivalence tests was already submitted to the Korea Food and Drug Administration (KFDA), any items will be excluded the current list of insurance-covered drugs from August 1 this year, unless otherwise approved by J...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK